Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 3:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 358 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: total hip arthroplasty Clear all

Conditions: Clinical Condition Included in the Approved Indications For Use for the Conformis Hip System
Interventions: Conformis Hip System; Device
Lead sponsor: Restor3D; Industry
Eligibility: 18 Years and older
Enrollment: 49 participants
Timeline: 2018 – 2022
U.S. locations: 6
States / cities: Roseville, California • Parker, Colorado • Boynton Beach, Florida + 3 more

Conditions: Osteoarthritis, Pain
Interventions: Patient may be able to put weight on the operated leg; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Hip Osteoarthritis, Surgery
Interventions: total hip arthroplasty; Procedure
Lead sponsor: Orthopedic One; Other
Eligibility: 18 Years to 75 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Dublin, Ohio

Conditions: Pain, Postoperative, Hip Arthroplasty
Interventions: CMP, Fascia Illica; Drug
Lead sponsor: Loyola University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Total Knee Arthroplasty (Postoperative Pain), Total Hip Arthroplasty (Postoperative Pain)
Interventions: Transcranial Direct Current Stimulation, Cognitive-Behavioral (CB) intervention; Device · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Osteoarthritis, Hip, Hip Disease
Interventions: MAKO THA 4.0 System; Device
Lead sponsor: American Hip Institute; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Des Plaines, Illinois

Conditions: Infection
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Orthostatic Hypotension
Interventions: Midodrine, Intravenous fluid bolus; Drug · Other
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 90 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Arthroplasty, Replacement, Hip
Interventions: Tranexamic Acid; Drug
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Osteoarthritis, Rheumatoid Arthritis, Arthritis, Avascular Necrosis, Acute Fracture
Interventions: Acetabular cup; Device
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: Not listed
Enrollment: 1,593 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2012
U.S. locations: 1
States / cities: Warsaw, Indiana

Conditions: Total Hip Replacement, Total Hip Arthroplasty
Interventions: Total Hip Arthroplasty; Device
Lead sponsor: Ortho Development Corporation; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2032
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Drainage
Interventions: Duraprep Surgical Solution; Drug
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years to 80 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Osteoarthritis
Interventions: Mini Incision Approach, 2 Incision Approach; Procedure
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Joint Diseases, Osteoarthritis, Hip, Rheumatoid Arthritis, Psoriatic Arthritis, Avascular Necrosis of Hip
Interventions: Routine Total Hip Arthroplasty; Device
Lead sponsor: Ortho Development Corporation; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Muscular Atrophy
Interventions: LY2495655, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 50 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 16
States / cities: Tucson, Arizona • Laguna Hills, California • Lakewood, Colorado + 13 more

Conditions: Opioid Use, Arthropathy of Knee, Arthropathy of Hip
Interventions: Not listed
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Osteoarthritis, Degenerative Joint Disease
Interventions: Bupivicaine + epinephrine, Bupivacaine, Ropivacaine, Ketorolac, Clonidine Injection; Drug
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Anesthesia, Opioid Use
Interventions: Guided mindfulness exercises, Self-administered aromatherapy, Baby aspirin, Tylenol/Acetaminophen, Pregabalin, Prednisone, Meloxicam, Prilosec, Tramadol, Voltaren, Zofran, Pepcid, Reglan, Versed, Lidocaine, Propofol, Ancef, Tranexamic Acid (TXA), Decadron, Bupivacaine hydrochloride, Toradol; Behavioral · Other · Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Osteoarthritis, Hip
Interventions: Dexamethasone, Bupivacaine, Epinephrine, Lumbar Plexus Nerve Block, Saline; Drug · Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 90 Years
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Osteoarthritis
Interventions: Arthroscopy, Arthroplasty; Procedure
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Arthroplasty Complications
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Arthroplasty, Replacement, Hip
Interventions: Testosterone Therapy, No Testosterone Therapy; Drug · Other
Lead sponsor: American Hip Institute; Other
Eligibility: 50 Years and older · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Des Plaines, Illinois

Conditions: Arthroplasty, Replacement, Hip
Interventions: Tritanium® Primary Acetabular Shell; Device
Lead sponsor: Stryker Orthopaedics; Industry
Eligibility: 18 Years and older
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2023
U.S. locations: 7
States / cities: St. Helena, California • Tampa, Florida • Lexington, Kentucky + 4 more

Conditions: Anterior Cruciate Ligament Reconstruction, Total Hip Arthroplasty (THA), Total Knee Arthroplasty, Hip Arthroscopy
Interventions: Visualization training with neurofeedback, Standard post-surgical rehabilitation therapy; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

A Study to Evaluate the Conformis Hip System

Safety of Non-delayed Weight Bearing After Total Hip Replacement With Non-Cemented Fiber Metal Taper Stem

Physical Therapy Following Total Hip Arthroplasty

CMP vs Fascia Iliaca Block

Effects of tDCS Combined With CBI on Postsurgical Pain

Multicenter Study for Robotic Arm-assisted THA 4.0 System: Hip Spine Relationship

Bacterial Contamination of Operative Splash Basins

An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty

Tranexamic Acid Study

Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement

Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty

Evaluating the Effectiveness of 2 Surgical Skin Preparation Methods in Reducing Surgical Wound Drainage After Total Hip or Knee Replacement

Study Comparing Mini-Incision Versus 2-Incision Approach for Total Hip Replacement

Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System

A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement

Opioid Consumption After Hospital Discharge in Orthopedic Surgery

Efficacy of Intraoperative Injections on Postoperative Pain Control During Total Hip Replacement

PROUD Study - Preventing Opioid Use Disorders

Systemic Steroids for Peripheral Nerve Blocks

Evaluation of Biomarkers in Human Synovial Fluid

Long-term Outcomes of Complex Conversion Total Hip Arthroplasty

Does Testosterone Therapy Improve Patient-Reported Outcomes in Age-Related Testosterone Deficient Patients Undergoing Total Hip Replacement: A Randomized-Controlled Trial

Tritanium® Primary Acetabular Shell Study

Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery